Skip to main content
Top
Published in: Critical Care 1/2018

Open Access 01-12-2018 | Letter

Experience of using beta-D-glucan assays in the intensive care unit

Authors: A. Dagens, N. Mughal, A. Sisson, L. S. P. Moore

Published in: Critical Care | Issue 1/2018

Login to get access

Excerpt

We read with interest the article by Giacobbe et al. [1] assessing the combined performance of serum (1,3)-β-D-glucan (BDG) and procalcitonin (PCT) for the differential diagnosis of candidaemia and bacteraemia in the intensive care setting. …
Literature
1.
go back to reference Giacobbe DR, Malgorzata M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, Mesini A, De Pascale G, Marchese A, Bruzzone M, Pelosi P, Mussap M, Molin A, Antonelli M, Posteraro B, Sanguinetti M, Viscoli C, Del Bono V. Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21:176.CrossRefPubMedPubMedCentral Giacobbe DR, Malgorzata M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, Mesini A, De Pascale G, Marchese A, Bruzzone M, Pelosi P, Mussap M, Molin A, Antonelli M, Posteraro B, Sanguinetti M, Viscoli C, Del Bono V. Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21:176.CrossRefPubMedPubMedCentral
Metadata
Title
Experience of using beta-D-glucan assays in the intensive care unit
Authors
A. Dagens
N. Mughal
A. Sisson
L. S. P. Moore
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2018
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-018-2044-7

Other articles of this Issue 1/2018

Critical Care 1/2018 Go to the issue